Taylor Swift’s Eras Tour, the billion-dollar juggernaut that has dominated the cultural calendar this year, may be on a break before picking up internationally, but its momentum will only rest so long: The show is coming to movie theaters this fall.
“Taylor Swift: The Eras Tour” concert film will be released in the United States, Canada and Mexico on Oct. 13, Swift announced on social media Thursday, with U.S. AMC Theaters promising at least four showtimes per day from Thursday to Sunday upon opening.
“The Eras Tour has been the most meaningful, electric experience of my life so far and I’m overjoyed to tell you that it’ll be coming to the big screen soon,” Swift said. “Eras attire, friendship bracelets, singing and dancing encouraged.”
Anticipating the white-hot demand that has followed the tour since its announcement, crashing ticketing systems around the world, AMC promised in a news release that it had “bolstered its ticket server capacity to handle traffic at more than 5 times the current record for the most ever tickets sold in an hour.” (The company added, however, that it was “also aware that no ticketing system in history seems to have been able to accommodate the soaring demand from Taylor Swift fans when tickets are first placed on sale.”)
Tickets are on sale now. Prices start at $19.89 for adults and $13.13 for children, substantially less than what fans paid for the tour itself — especially on the robust secondary market — as the concert industry adjusts to sometimes prohibitively high costs for its biggest events.
Swift, 33, wrapped this year’s North American dates with four shows in Mexico last week. Her downtime, though, will be brief. In addition to the movie version of the concert, the singer will release “1989 (Taylor’s Version),” the fourth of rerecorded original albums, two weeks later, on Oct. 27. By November, the Eras Tour will pick up in Argentina before traveling around the world in 2024, with dates — including nine additional U.S. shows — continuing into November 2024.
“1989 (Taylor’s Version),” the new edition of her 2014 pop blockbuster, marks Swift’s seventh release in barely three years, a period of artistic productivity that has fueled pent-up, post-pandemic demand for the singer’s live show. Jon Caramanica, a critic for The New York Times, said in a review of the first concert in March that the Eras Tour put on display “how many pivots Swift has undertaken in her career, and how the accompanying risks can have wildly different consequences.”
The trade publication Pollstar has estimated that the singer sold about $14 million in tickets for each show so far. By the end of next year, the 146 stadium dates could reach $1.4 billion or more in sales.
